PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron.

Arpan AcharyaAnup S PathaniaKabita PandeyMichellie ThurmanKendra R VannTatiana G KutateladzeKishore B ChallagundalaDonald L DurdenSiddappa N Byrareddy

Published in: Clinical and translational medicine (2022)

Keyphrases

sars cov
copy number
respiratory syndrome coronavirus
cell proliferation